Chlorpromazine induces hyposalivation by inhibiting muscarinic Ca2+ signaling in salivary glands
Naunyn-Schmiedeberg's Archives of Pharmacology · 2026
DOI: 10.1007/s00210-025-04438-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Yoon-Jung Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, 03080, Republic of Korea. Hauptthemen laut MEDLINE: Chlorpromazine, Calcium Signaling, Salivary Glands, Receptors, Muscarinic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Seoul National University.
Abstract (Originalsprache)
Chlorpromazine (CPZ), a dopamine D2 receptor antagonist, is an antipsychotic drug widely used in the treatment of schizophrenia. While CPZ is known to induce hyposalivation, the exact mechanism by which it inhibits secretory function in the salivary glands remains unclear. In this study, we investigated the molecular mechanism underlying CPZ-induced hyposalivation. Our findings confirmed that CPZ decreases salivation by inhibiting muscarinic signaling in a dose-dependent manner in a mouse model. By analyzing a single-cell RNA sequencing (scRNA-seq) database, we searched known CPZ targets in salivary gland cells and found that dopamine receptors are not expressed in these cells. CPZ inhibited the increase in intracellular Ca 2+ triggered by muscarinic and histamine receptors in human salivary gland cells. This inhibition involved both the release of Ca 2+ from the endoplasmic reticulum (ER) and the influx of extracellular Ca 2+ through store-operated Ca 2+ entry (SOCE). These findings suggest that in salivary glands, CPZ induces hyposalivation by inhibiting Ca 2+ signaling through multiple sites of action, including muscarinic receptor and SOCE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, 03080, Republic of Korea.
- Department of Oral Medicine and Oral Diagnosis, Dental Research Institute, Seoul National University School of Dentistry, Seoul, 03080, Republic of Korea. dentopark@snu.ac.kr.
- Department of Oral Medicine, Seoul National University Dental Hospital, Seoul, 03080, Republic of Korea. dentopark@snu.ac.kr.
- Department of Physiology, Dental Research Institute, Seoul National University School of Dentistry, Seoul, 03080, Republic of Korea. sychoi@snu.ac.kr.
Förderung
- National Research Foundation of Korea
- Seoul National University
Zitieren
APA
Kim, Y. J., Kim, Y. B., Kim, S., Choi, T. Y., Park, H. K., & Choi, S. Y. (2026). Chlorpromazine induces hyposalivation by inhibiting muscarinic Ca2+ signaling in salivary glands. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04438-8
Vancouver
Kim YJ, Kim YB, Kim S, Choi TY, Park HK, Choi SY. Chlorpromazine induces hyposalivation by inhibiting muscarinic Ca2+ signaling in salivary glands. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-025-04438-8
BibTeX
@article{Kim2026,
author = {Kim, Yoon-Jung and Kim, Yoo-Bin and Kim, Soohyun and Choi, Tae-Yong and Park, Hee-Kyung and Choi, Se-Young},
title = {Chlorpromazine induces hyposalivation by inhibiting muscarinic Ca2+ signaling in salivary glands},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-025-04438-8}
}
EUVIMED